What Could New and Promising Treatment Options Mean for CLL Patients?

patientpower has 1515 videos Subscribe Here

Description: A new treatment, ibrutinib (Imbruvica), was recently approved by the Food and Drug Administration (FDA) for use in CLL patients who have received at least one previous therapy. Dr. Susan O'Brien, a leading CLL expert from MD Anderson Cancer Center, joins us to explain what she feels this new option--and other promising treatments in development--could mean for some CLL patients.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Shared By : patientpower
Posted on : 02/19/14
Added : 3 years ago
Category : Other

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)